Keyphrases
1000 Genomes Project
8%
Accuracy Improvement
6%
Acute Lymphoblastic Leukemia
6%
Acute Myeloid Leukemia
15%
Aneuploidy
7%
Breast Cancer
17%
Cancer Drivers
6%
Cancer Genes
10%
Cancer Genome
21%
Cancer Genome Atlas
43%
Cancer Genomics
8%
Cancer Types
47%
Clear Cell Renal Cell Carcinoma (ccRCC)
10%
Clinically Significant
8%
Clonal Architecture
8%
Comprehensive Characterization
9%
Copy number
10%
Copy number Variation
17%
Diacylglycerol Kinase
8%
DNA Methylation (DNAm)
8%
DNA Sequencing
18%
Driver mutations
14%
Druggability
7%
Endometrial Cancer
6%
Endometrial Carcinoma
6%
Gene Expression
13%
Gene Fusion
8%
Genetic Modification
18%
Genome Analysis
16%
Genome Sequencing
9%
Genomic Analysis
7%
Genomic Characterization
11%
Genomic Landscape
17%
Germ Cells
11%
Germline Variants
7%
Glioblastoma
11%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
7%
Helix
7%
High-risk Human Papillomavirus (HR-HPV)
6%
Human Cancer
36%
Human Genome
20%
In Cancer
56%
Long Non-coding RNA (LncRNA)
7%
Lung Adenocarcinoma
12%
Massively Parallel Sequencing
7%
Melanoma
7%
Microenvironment
9%
MicroRNA
7%
Microsatellite Instability-high (MSI-H)
8%
Mitochondrial DNA
6%
Molecular Characterization
18%
Molecular Features
8%
Multiple Myeloma
10%
Multiple Scattering
20%
Mutated Genes
6%
Myelodysplastic Syndrome
7%
Near-edge X-ray Absorption Fine Structure (NEXAFS)
18%
Next-generation Sequencing
6%
Non-coding
8%
Oncogene
6%
Ovarian Cancer
7%
Pan-cancer
24%
Pan-cancer Analysis
59%
Pancreatic Cancer
7%
Pancreatic Ductal Adenocarcinoma
9%
Path Analysis
7%
Patient-derived Xenograft
17%
Pediatric
8%
Precision Oncology
6%
Primary Tumor
8%
Proteogenomics
50%
Proteomic Analysis
12%
Proteomics
14%
Pseudoknot
6%
RNA Pseudoknot
8%
RNA Sequencing (RNA-seq)
9%
Sequence Data
15%
Shotgun Sequencing
7%
Signaling Pathway
7%
Single nucleotide Polymorphism
7%
Single nucleotide Variant
8%
Single-cell RNA Sequencing (scRNA-seq)
7%
Somatic Alterations
7%
Somatic mutation
31%
Structural Variants
22%
Structural Variation
13%
TP53 mutation
8%
Transcriptomics
7%
Tumor
100%
Tumor Cells
8%
Tumor Protein p53 (TP53)
13%
Tumor Samples
11%
Tumor Subtype
20%
Tumor Suppressor
6%
Tumorigenesis
9%
Virus
6%
Whole Exome Sequencing
12%
Whole Genome
57%
Whole Genome Sequencing
27%
Whole-genome Sequence Data
11%
Biochemistry, Genetics and Molecular Biology
Allele
9%
Alpha Thalassemia/Mental Retardation X-Linked
8%
Alternative Splicing
5%
Aneuploidy
9%
Autosomal Dominant Inheritance
5%
BRCA1
6%
Cancer Cell
14%
Cancer Genome Sequencing
6%
Carcinogenesis
28%
Chromosome Instability
7%
Colon
8%
Deep Sequencing
14%
DNA Methylation
21%
DNA Sequence
28%
Dynamics
5%
Energy Landscape
5%
Enhancer Region
5%
Epidermal Growth Factor Receptor
18%
Epigenetics
19%
Epigenomics
7%
Exome
15%
Exome Sequencing
16%
Exon
10%
GATA3
5%
Gene Amplification
5%
Gene Dosage
8%
Gene Expression
20%
Gene Frequency
7%
Gene Fusion
13%
Gene Mutation
22%
Genetic Divergence
6%
Genetic Variation
8%
Genetics
39%
Genome Sequencing
8%
Genotyping
6%
Germ Cell
22%
Germline
22%
Haplotype
6%
Hepatitis B Virus
6%
Histone
5%
Human Genetics
6%
Human Genome
25%
Immune Checkpoints
5%
Immunocompetent Cell
6%
Indel
23%
Kinase
12%
KRAS
9%
Long Non-Coding RNA
8%
Mass Spectrometry
6%
Messenger RNA
18%
Messenger RNA
5%
Metabolic Pathway
7%
Methylation
10%
MicroRNA
17%
Microsatellite Instability
5%
Missense
6%
Mitogen-Activated Protein Kinase
5%
Mouse
12%
Mutated Genes
14%
Mutation Rate
10%
Myeloid
27%
Next Generation Sequencing
13%
Oncogene
19%
Overall Survival
5%
Phosphoproteomics
6%
Phosphotransferase
12%
Point Mutation
7%
Posttranslational Modification
5%
Prevalence
5%
Promoter Region
12%
Proteogenomics
50%
Proteome
5%
Proteomics
36%
Pseudoknot
8%
Receptor Tyrosine Kinase
6%
RNA
27%
RNA Sequence
18%
RNA Sequencing
14%
Signal Transduction
17%
Single-Nucleotide Polymorphism
21%
Somatic Mutation
47%
T Cell
7%
Telomerase
6%
Transcription Factors
7%
Transcriptome
14%
Transcriptomics
19%
Tumor Gene
10%
Tumor Progression
13%
Tumor Suppressor Gene
5%
Tumor Suppressor Protein
7%
Upregulation
5%
Volume
9%
Wart Virus
7%
Whole Genome Sequencing
50%